L&G Pharma Breakthrough UCITS ETF (GBP) | BIGTRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 30/04/2024 |
|
Annual Returns (GBP) | 30/04/2024 | |||||||
2019 | 2020 | 2021 | 2022 | 2023 | 30/04 | |||
Price Return | 12.67 | 27.09 | -3.85 | -7.26 | -10.26 | -9.73 | ||
+/- Category | -7.53 | 1.12 | 5.19 | 0.57 | -8.98 | -5.93 | ||
+/- Category Index | -4.04 | -5.84 | -4.15 | -9.73 | -17.60 | -16.17 | ||
% Rank in Category | 95 | 33 | 44 | 19 | 93 | 85 |
Trailing Returns (GBP) | 17/05/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | -0.50 | 0.00 | 0.39 |
1 Week | -0.39 | 0.19 | -1.32 |
1 Month | 6.26 | 2.84 | 0.68 |
3 Months | -0.89 | 1.87 | -4.99 |
6 Months | -3.68 | -20.33 | -20.01 |
YTD | -6.08 | -6.01 | -16.15 |
1 Year | -17.09 | -19.28 | -33.33 |
3 Years Annualised | -4.57 | -2.12 | -13.69 |
5 Years Annualised | 0.81 | -5.33 | -11.83 |
10 Years Annualised | - | - | - |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 30/04/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | -6.47 | - | - | - |
2023 | -4.06 | -3.52 | -5.35 | 2.43 |
2022 | -4.80 | -8.65 | -5.64 | 13.00 |
2021 | -5.55 | 6.72 | -2.85 | -1.81 |
2020 | -8.82 | 26.92 | 3.36 | 6.26 |
2019 | 11.43 | -3.77 | -10.35 | 17.20 |
|
Advertisement |